Pulmonary edema, characterized by the accumulation of fluid in the alveolar spaces, can lead to impaired gas exchange, severe shortness of breath, and life-threatening respiratory compromise if not addressed promptly. Pulmonary edema care requires rapid assessment, identification of underlying causes, and timely intervention to stabilize the patient and prevent recurrence. Common causes include heart failure, acute kidney injury, fluid overload, and acute respiratory distress syndrome, each necessitating targeted management strategies. Care typically involves oxygen therapy to maintain adequate saturation, diuretics to reduce fluid overload, and medications to optimize cardiac function when cardiogenic factors are present. Non-invasive ventilation or mechanical support may be required in severe cases to assist breathing and reduce pulmonary pressures. Pulmonary edema care also emphasizes continuous monitoring of vital signs, oxygenation, and fluid balance, alongside supportive measures such as patient positioning to improve lung expansion. Multidisciplinary collaboration among pulmonologists, cardiologists, critical care specialists, and nursing teams ensures comprehensive and coordinated management. Early recognition and intervention are critical to preventing complications, reducing hospitalization duration, and improving patient outcomes. Research and clinical practice highlight the importance of addressing both acute management and long-term preventive strategies, including optimization of underlying cardiovascular or renal conditions. Effective pulmonary edema care combines rapid response, targeted therapy, and ongoing monitoring to preserve lung function, enhance patient safety, and improve overall respiratory health in affected individuals.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation